United Therapeutics Corporation (UTHR)
Net profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 1,195,100 | 1,110,900 | 1,069,400 | 1,050,500 | 984,800 | 899,800 | 871,500 | 728,300 | 727,300 | 707,400 | 630,800 | 687,400 | 475,800 | 462,400 | 470,900 | 405,400 | 514,800 | 468,600 | 429,800 | 527,800 |
Revenue (ttm) | US$ in thousands | 2,877,400 | 2,756,200 | 2,616,700 | 2,498,300 | 2,327,500 | 2,204,300 | 2,110,900 | 1,981,300 | 1,936,300 | 1,860,000 | 1,788,700 | 1,768,300 | 1,685,500 | 1,655,200 | 1,590,600 | 1,506,100 | 1,483,300 | 1,409,500 | 1,430,900 | 1,442,500 |
Net profit margin | 41.53% | 40.31% | 40.87% | 42.05% | 42.31% | 40.82% | 41.29% | 36.76% | 37.56% | 38.03% | 35.27% | 38.87% | 28.23% | 27.94% | 29.61% | 26.92% | 34.71% | 33.25% | 30.04% | 36.59% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $1,195,100K ÷ $2,877,400K
= 41.53%
The net profit margin of United Therapeutics Corporation has shown some fluctuations over the years, ranging from a low of 26.92% in March 2021 to a high of 42.31% in December 2023. Overall, the company has maintained a healthy net profit margin, staying above 30% for most periods. The upward trend in the net profit margin from 2022 to 2024 indicates improving profitability and efficiency in managing costs relative to revenue. Investors and stakeholders may view this positively as it demonstrates the company's ability to generate profits from its operations. However, it is important to continue monitoring the net profit margin to ensure sustained profitability in the long term.
Peer comparison
Dec 31, 2024